English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [886]
News [1829]
Articles [244]
Editorials [5]
Conferences [135]
elearning [18]
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival...
Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology...
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC ( Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology, Trondheim, Norway )
10 Jun 2026
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical...
Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman...
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses ( Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman Stålnacke )
8 Jun 2026
2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact...
Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke
2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management ( Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke )
8 Jun 2026
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in...
Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )
1 Jun 2026
Implanted tile-based radiation shows promise compared with stereotactic...
Dr Jeffrey Weinberg - MD Anderson Cancer Center, Houston, USA
Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases ( Dr Jeffrey Weinberg - MD Anderson Cancer Center, Houston, USA )
31 May 2026
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable...
Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma ( Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China )
30 May 2026
Low-dose CT screening reduces lung cancer mortality and improves survival in...
Dr Caichen Li - Guangzhou Medical University, Guangzhou, China
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li  - Guangzhou Medical University, Guangzhou, China )
13 Apr 2026
Durvalumab after SBRT reduces tumour progression in early-stage NSCLC
Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden
Durvalumab after SBRT reduces tumour progression in early-stage NSCLC ( Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden )
13 Apr 2026
Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS...
Dr Aly-Khan Lalani - McMaster University, Hamilton, Canada
Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe ( Dr Aly-Khan Lalani - McMaster University, Hamilton, Canada )
17 Mar 2026
Transforming radiotherapy skin care by recognising diverse skin reactions
Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK
Transforming radiotherapy skin care by recognising diverse skin reactions ( Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK )
26 Jan 2026
Improving African representation in breast cancer genomics
Dr Ricardo Pinto - i3S, Porto, Portugal
Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL...
Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT ( Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA )
22 Dec 2025
<12345…74>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top